Own a profitable toxicology laboratory delivering $1M EBITDA with established revenue streams and proven market demand. This turnkey operation positions you to capitalize on the growing healthcare testing market while serving critical community needs in recovery and clinical decision support.

You'll acquire a fully integrated lab service with proprietary testing methodologies that generate consistent cash flow through diverse client relationships spanning recovery centers, healthcare providers, and custom testing contracts. The business leverages cutting-edge innovation to deliver superior results, creating strong client retention and premium pricing power.

This investment delivers immediate income generation with significant growth potential. The established customer base provides predictable revenue while the comprehensive service offerings create multiple expansion opportunities. You'll benefit from:

• Proven $1M EBITDA performance demonstrating strong profitability
• Diversified revenue streams reducing client concentration risk
• Proprietary testing methods creating competitive advantages
• Essential services generating recession-resistant demand
• Scalable operations ready for market expansion
• Established relationships in high-growth healthcare sectors

The business addresses critical market needs including medication therapy monitoring, substance identification, drug interaction detection, and treatment plan optimization. This positions you to capture growing demand as healthcare providers increasingly rely on objective testing for clinical decisions.

You'll step into a turnkey operation with experienced systems, proven processes, and established vendor relationships. The business model supports both lifestyle flexibility and growth ambitions, whether you choose hands-on management or strategic oversight.

This represents an exceptional opportunity to own a profitable, essential healthcare service business with strong fundamentals, diverse revenue streams, and significant expansion potential in Miami's robust medical market.